Published in Transplantation on May 15, 2007
Kidney, pancreas and liver allocation and distribution in the United States. Am J Transplant (2012) 1.24
Point: steady progress and current challenges in clinical islet transplantation. Diabetes Care (2009) 1.20
One hundred human pancreatic islet isolations at Baylor Research Institute. Proc (Bayl Univ Med Cent) (2010) 0.86
The role of kidney-pancreas transplantation in diabetic kidney disease. Curr Diab Rep (2010) 0.80
Pancreas transplantation: lessons learned from a decade of experience at Wake Forest Baptist Medical Center. Rev Diabet Stud (2011) 0.79
The new deceased donor pancreas allocation schema: do the recommendations go far enough? Transplantation (2007) 0.75
Donor Characteristics of Pancreas Transplantation in Australia and New Zealand: A Cohort Study 1984-2014. Transplant Direct (2016) 0.75
Pancreas transplantation: differences in activity between Europe and the United States. Nephrol Dial Transplant (2009) 0.75
Extended pancreas donor program - the EXPAND study rationale and study protocol. Transplant Res (2013) 0.75
Bioencapsulation technologies in tissue engineering. J Appl Biomater Funct Mater (2016) 0.75
Transplantable bioartificial pancreas devices: current status and future prospects. Langenbecks Arch Surg (2015) 0.75
Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med (2003) 8.47
Perioperative mortality and long-term survival following live kidney donation. JAMA (2010) 7.34
Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. Liver Transpl (2012) 4.65
A comprehensive risk quantification score for deceased donor kidneys: the kidney donor risk index. Transplantation (2009) 4.45
US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis (2015) 3.94
Survival after pancreas transplantation in patients with diabetes and preserved kidney function. JAMA (2003) 3.33
Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care (2012) 3.20
Morbidity and mortality after living kidney donation, 1999-2001: survey of United States transplant centers. Am J Transplant (2003) 2.95
Longitudinal assessment of mortality risk among candidates for liver transplantation. Liver Transpl (2003) 2.68
Management of the Potential Organ Donor in the ICU: Society of Critical Care Medicine/American College of Chest Physicians/Association of Organ Procurement Organizations Consensus Statement. Crit Care Med (2015) 2.42
Donor kidney exchanges. Am J Transplant (2004) 2.39
Laparoscopic live donor nephrectomy: a risk factor for delayed function and rejection in pediatric kidney recipients? A UNOS analysis. Am J Transplant (2005) 2.29
Sirolimus reduces polycystic liver volume in ADPKD patients. J Am Soc Nephrol (2008) 2.26
Rates of solid-organ wait-listing, transplantation, and survival among residents of rural and urban areas. JAMA (2008) 2.24
Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int (2002) 2.10
HLA-DR matching in organ allocation: balance between waiting time and rejection in pediatric kidney transplantation. Arch Surg (2011) 2.09
Estimates of early death, acute liver failure, and long-term mortality among live liver donors. Gastroenterology (2011) 2.07
A selective IKK-2 inhibitor blocks NF-kappa B-dependent gene expression in interleukin-1 beta-stimulated synovial fibroblasts. J Biol Chem (2003) 1.98
Insurance type and minority status associated with large disparities in prelisting dialysis among candidates for kidney transplantation. Clin J Am Soc Nephrol (2008) 1.98
Racial and ethnic disparities in access to liver transplantation. Liver Transpl (2010) 1.94
Transplant glomerulopathy: risk and prognosis related to anti-human leukocyte antigen class II antibody levels. Transplantation (2008) 1.92
Association of center volume with outcome after liver and kidney transplantation. Am J Transplant (2004) 1.92
Increased transplanted organs from the use of a standardized donor management protocol. Am J Transplant (2002) 1.92
Immunosuppression and the risk of post-transplant malignancy among cadaveric first kidney transplant recipients. Am J Transplant (2004) 1.90
Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation. Transplantation (2003) 1.88
Effect of alcoholic liver disease and hepatitis C infection on waiting list and posttransplant mortality and transplant survival benefit. Hepatology (2009) 1.84
Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQITM) conference. Clin J Am Soc Nephrol (2008) 1.76
Living kidney donors in need of kidney transplants: a report from the organ procurement and transplantation network. Transplantation (2002) 1.65
Predictors associated with terminal renal function in deceased organ donors in the intensive care unit. Anesthesiology (2009) 1.60
Outcome of patients with hepatitis B virus and human immunodeficiency virus infections referred for liver transplantation. Liver Transpl (2006) 1.59
Antibody-mediated rejection despite inhibition of terminal complement. Transpl Int (2014) 1.52
Long-term outcomes of patients with light chain amyloidosis (AL) after renal transplantation with or without stem cell transplantation. Nephrol Dial Transplant (2011) 1.51
Aggressive pharmacologic donor management results in more transplanted organs. Transplantation (2003) 1.45
Satisfaction With Life Among Living Kidney Donors: A RELIVE Study of Long-Term Donor Outcomes. Transplantation (2014) 1.45
Trends over a decade of pediatric liver transplantation in the United States. Liver Transpl (2006) 1.45
Kidney and pancreas transplantation. Am J Transplant (2003) 1.45
Post-transplant de novo malignancies in renal transplant recipients: the past and present. Transpl Int (2006) 1.45
Portal vein thrombosis and liver transplant survival benefit. Liver Transpl (2010) 1.42
Review of solid-organ transplantation in HIV-infected patients. Transplantation (2003) 1.37
Current status of kidney and pancreas transplantation in the United States, 1994-2003. Am J Transplant (2005) 1.37
Liver allografts from hepatitis C positive donors can offer good outcomes in hepatitis C positive recipients: a US National Transplant Registry analysis. Transpl Int (2010) 1.25
Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockade. Transplantation (2010) 1.23
Early mortality rates in older kidney recipients with comorbid risk factors. Transplantation (2007) 1.22
Delayed hepatocellular carcinoma model for end-stage liver disease exception score improves disparity in access to liver transplant in the United States. Hepatology (2015) 1.20
Transplant tumor registry: donor related malignancies. Transplantation (2002) 1.19
Pediatric transplantation, 1994-2003. Am J Transplant (2005) 1.19
Hormonal resuscitation yields more transplanted hearts, with improved early function. Transplantation (2003) 1.18
Immunosuppression: evolution in practice and trends, 1993-2003. Am J Transplant (2005) 1.17
The report of a national conference on the wait list for kidney transplantation. Am J Transplant (2003) 1.14
Successful clinical islet isolation using a GMP-manufactured collagenase and neutral protease. Transplantation (2009) 1.11
Impact of the expanded criteria donor allocation system on the use of expanded criteria donor kidneys. Transplantation (2005) 1.10
Analysis of the wait list and deaths among candidates waiting for a kidney transplant. Transplantation (2008) 1.10
Cyclosporine pharmacokinetics and dosing modifications in human immunodeficiency virus-infected liver and kidney transplant recipients. Transplantation (2005) 1.10
Prevalence and outcomes of multiple-listing for cadaveric kidney and liver transplantation. Am J Transplant (2004) 1.07
Effect of pretransplant serum creatinine on the survival benefit of liver transplantation. Liver Transpl (2009) 1.06
Patient-specific prediction of ESRD after liver transplantation. J Am Soc Nephrol (2013) 1.04
Organ donation and utilization in the USA. Am J Transplant (2004) 1.03
Similar risk profiles for post-transplant renal dysfunction and long-term graft failure: UNOS/OPTN database analysis. Kidney Int (2004) 1.01
End stage polycystic kidney disease: indications and timing of native nephrectomy relative to kidney transplantation. J Urol (2005) 1.00
Pharmacodynamics, pharmacokinetics, and safety of multiple doses of FTY720 in stable renal transplant patients: a multicenter, randomized, placebo-controlled, phase I study. Transplantation (2003) 1.00
Short-term pretransplant renal replacement therapy and renal nonrecovery after liver transplantation alone. Clin J Am Soc Nephrol (2013) 0.99
Impact of the expanded criteria donor allocation system on candidates for and recipients of expanded criteria donor kidneys. Transplantation (2007) 0.99
Epidemiology of infections requiring hospitalization during long-term follow-up of pancreas transplantation. Transplantation (2010) 0.99
Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation. Transplantation (2004) 0.98
Gender imbalance in living donor renal transplantation. Transplantation (2002) 0.97
Kidney and pancreas transplantation. Am J Transplant (2004) 0.96
ABO-incompatible kidney transplantation. Transplantation (2004) 0.96
Internet-based intervention to promote organ donor registry participation and family notification. Transplantation (2003) 0.95
Liver and kidney transplantation in HIV-infected patients. AIDS Rev (2009) 0.95
Determinants of transplant surgeons' willingness to provide organs to patients infected with HBV, HCV or HIV. Am J Transplant (2005) 0.95
Transplantation in the diabetic patient with advanced chronic kidney disease: a task force report. Am J Kidney Dis (2004) 0.95
BKV in simultaneous pancreas-kidney transplant recipients: a leading cause of renal graft loss in first 2 years post-transplant. Am J Transplant (2005) 0.93
Transplant tumor registry: donors with central nervous system tumors1. Transplantation (2002) 0.93
Solid organ transplantation: referral, management, and outcomes in HIV-infected patients. AIDS Read (2006) 0.93
Renal transplantation in patients with HIV. Nat Rev Nephrol (2009) 0.92
An analysis of the lack of donor pancreas utilization from younger adult organ donors. Transplantation (2010) 0.92
Balancing efficacy and toxicity in kidney-transplant immunosuppression. N Engl J Med (2007) 0.91
Clinical results of an organ procurement organization effort to increase utilization of donors after cardiac death. Transplantation (2006) 0.91
Review of transplantation in HIV patients during the HAART era. Clin Transpl (2004) 0.91
Differential expression of chemokines and chemokine receptors in murine islet allografts: the role of CCR2 and CCR5 signaling pathways. J Am Soc Nephrol (2004) 0.91
Kidney vending: the "Trojan horse" of organ transplantation. Clin J Am Soc Nephrol (2006) 0.91
Liver transplantation in HIV-infected recipients. Semin Liver Dis (2006) 0.90
Solid organ transplantation is a reality for patients with HIV infection. Curr HIV/AIDS Rep (2006) 0.89
Deceased donors with a past history of malignancy: an organ procurement and transplantation network/united network for organ sharing update. Transplantation (2007) 0.88
Living donor kidney transplantation using laparoscopically procured multiple renal artery kidneys and right kidneys. J Am Coll Surg (2013) 0.87
Best single time point correlations with AUC for cyclosporine and tacrolimus in HIV-infected kidney and liver transplant recipients. Transplantation (2014) 0.87
Down-regulating humoral immune responses: implications for organ transplantation. Transplantation (2014) 0.87
Clinical Trials for Immunosuppression in Transplantation; The Case for Reform and Change in Direction. Transplantation (2017) 0.87
Key clinical, ethical, and policy issues in the evaluation of the safety and effectiveness of solid organ transplantation in HIV-infected patients. Arch Intern Med (2003) 0.87
Evolution of endpoints for renal transplant outcome. Am J Transplant (2003) 0.86
Skin cancer in organ transplant recipients: effect of pretransplant end-organ disease. J Am Acad Dermatol (2005) 0.86
Survival of mandatorily shared cadaveric kidneys and their paybacks in the zero mismatch era. Transplantation (2002) 0.85
Preemptive living donor kidney transplantation: do the benefits extend to all recipients? Transplantation (2007) 0.85
Kidney transplantation after previous liver transplantation: analysis of the organ procurement transplant network database. Transplantation (2011) 0.85